Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan;25(1):78-90.
doi: 10.1007/s12094-022-02935-3. Epub 2022 Sep 8.

Nanoimmunoengineering strategies in cancer diagnosis and therapy

Robabehbeygom Ghafelehbashi  1   2 , Melina Farshbafnadi  2   3 , Niloofar Shokraneh Aghdam  4 , Shahin Amiri  5   6 , Mitra Salehi  7 , Sepideh Razi  8   9   10
Affiliations
Review

Nanoimmunoengineering strategies in cancer diagnosis and therapy

Robabehbeygom Ghafelehbashi et al. Clin Transl Oncol. 2023 Jan.

Abstract

Cancer immunotherapy strategies in combination with engineered nanosystems have yielded beneficial results in the treatment of cancer and their application is increasing day by day. The pivotal role of stimuli-responsive nanosystems and nanomedicine-based cancer immunotherapy, as a subsidiary discipline in the field of immunology, cannot be ignored. Today, rapid advances in nanomedicine are used as a platform for exploring new therapeutic applications and modern smart healthcare management strategies. The progress of nanomedicine in cancer treatment has confirmed the findings of immunotherapy in the medical research phase. This study concentrates on approaches connected to the efficacy of nanoimmunoengineering strategies for cancer immunotherapies and their applications. By assessing improved approaches, different aspects of the nanoimmunoengineering strategies for cancer therapies are discussed in this study.

Keywords: Cancer; Diagnosis; Nanoimmunoengineering; Therapy.

PubMed Disclaimer

References

    1. Goldberg MS. Immunoengineering: how nanotechnology can enhance cancer immunotherapy. Cell. 2015;161(2):201–4. - DOI
    1. Jeanbart L, Swartz MA. Engineering opportunities in cancer immunotherapy. Proc Natl Acad Sci USA. 2015;112(47):14467–72. - DOI
    1. Stanculeanu DL, Daniela Z, Lazescu A, Bunghez R, Anghel R. Development of new immunotherapy treatments in different cancer types. J Med Life. 2016;9(3):240–8.
    1. Rosenberg SA, Restifo NP. Adoptive cell transfer as personalized immunotherapy for human cancer. Science. 2015;348(6230):62–8. - DOI
    1. Liu Z, Jiang W, Nam J, Moon JJ, Kim BYS. Immunomodulating nanomedicine for cancer therapy. Nano Lett. 2018;18(11):6655–9. - DOI

LinkOut - more resources